Are you looking forward to shedding the weight for good, boosting your energy, and claiming back your right to a healthy life
A recent University College London research estimates that 1.6 million adults in England, Wales and Scotland used GLP-1s, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro), between early 2024 and early 2025, to lose weight.
Contact us today to schedule a consultation and learn more Lose Weight & Your Appetite Benefits FDA Approved Reduces Appetite Increases Fullness Slows Digestion Promotes Significant Weight Loss Improves Metabolic Health Helps Regulate Blood Sugar Cardio Protective Convenient Treatment Option Long-Term Weight Loss Complements Lifestyle Changes *Florida Weight Loss & Anti-Aging Center makes no claims that these results are representative of all participants in the weight loss program
Stay in your lane (medical management, behavioral support within your expertise) and refer out for specialized nutrition counseling or exercise programming if needed
Most patients begin noticing appetite suppression and weight loss within 2 to 4 weeks at their initial 0.25 mg dose
Offers a wide range of metabolic and hormonal compounding services